Development of heterodimeric estrogen receptor alpha antagonists to target simultaneously the ligand and coactivator binding site.


Journal

Archiv der Pharmazie
ISSN: 1521-4184
Titre abrégé: Arch Pharm (Weinheim)
Pays: Germany
ID NLM: 0330167

Informations de publication

Date de publication:
Jul 2023
Historique:
revised: 07 04 2023
received: 09 12 2022
accepted: 12 04 2023
medline: 6 7 2023
pubmed: 13 5 2023
entrez: 13 5 2023
Statut: ppublish

Résumé

One-third of breast cancer patients will develop recurrent cancer within 15 years of endocrine treatment. Notably, tumor growth in a hormone-refractory state still relies on the interaction between estrogen receptor alpha (ERα) and upregulated coactivators. Herein, we suggest that simultaneous targeting of the primary ligand binding site (LBS) and the coactivator binding site (CABS) at ERα represents a promising alternative therapeutic strategy to overcome mutation-driven resistance in breast cancer. We synthesized two series of compounds that connect the LBS-binder (E)-3-{4-[8-fluoro-4-(4-hydroxyphenyl)-2,3-dihydrobenzo[b]oxepin-5-yl]phenyl}acrylic acid 8 with the coactivator binding site inhibitors (CBIs) 4,6-bis(isobutyl(methyl)amino)pyrimidine or 3-(5-methoxy-1H-benzo[d]imidazol-2-yl)propanoic acid via covalent linkage. The most active benzoxepine-pyrimidine conjugate 31 showed strong inhibition of estradiol-induced transactivation (IC

Identifiants

pubmed: 37173820
doi: 10.1002/ardp.202200638
doi:

Substances chimiques

acrylic acid J94PBK7X8S
Estrogen Receptor alpha 0
Estrogen Receptor beta 0
Ligands 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e2200638

Informations de copyright

© 2023 The Authors. Archiv der Pharmazie published by Wiley-VCH GmbH on behalf of Deutsche Pharmazeutische Gesellschaft.

Références

N. Azamjah, Y. Soltan-Zadeh, F. Zayeri, Cancer Prev. 2019, 20, 2015.
N. Harbeck, M. Gnant, Lancet 2017, 389, 1134.
D. Bafna, F. Ban, P. S. Rennie, K. Singh, A. Cherkasov, Int. J. Mol. Sci. 2020, 21, 1.
N. M. O'Boyle, I. Barrett, L. M. Greene, M. Carr, D. Fayne, B. Twamley, A. J. S. Knox, N. O. Keely, D. M. Zisterer, M. J. Meegan, J. Med. Chem. 2018, 61, 514.
A. Milani, World J. Clin. Oncol. 2014, 5, 990.
T. Reinert, C. H. Barrios, Ther. Adv. Med. Oncol. 2017, 9, 693.
R. Xiong, J. Zhao, L. M. Gutgesell, Y. Wang, S. Lee, B. Karumudi, H. Zhao, Y. Lu, D. A. Tonetti, G. R. J. Thatcher, J. Med. Chem. 2017, 60, 1325.
A. Lai, M. Kahraman, S. Govek, J. Nagasawa, C. Bonnefous, J. Julien, K. Douglas, J. Sensintaffar, N. Lu, K. Lee, A. Aparicio, J. Kaufman, J. Qian, G. Shao, R. Prudente, M. J. Moon, J. D. Joseph, B. Darimont, D. Brigham, K. Grillot, R. Heyman, P. J. Rix, J. H. Hager, N. D. Smith, J. Med. Chem. 2015, 58, 4888.
Z. Wang, Z. Ma, Z. Shen, J. Steroid Biochem. Mol. Biol. 2021, 209, 1.
R. B. Kargbo, ACS Med. Chem. Lett. 2019, 10, 1367.
Y. Elahmad, M. Tabart, F. Halley, V. Certal, F. Thompson, B. Filoche-Rommé, F. Gruss-Leleu, C. Muller, M. Brollo, L. Fabien, V. Loyau, L. Bertin, P. Richepin, F. Pilorge, P. Desmazeau, C. Girardet, S. Beccari, A. Louboutin, G. Lebourg, J. Le-Roux, C. Terrier, F. Vallée, V. Steier, M. Mathieu, A. Rak, P. Y. Abecassis, P. Vicat, T. Benard, M. Bouaboula, F. Sun, M. Shomali, A. Hebert, M. Levit, H. Cheng, A. Courjaud, C. Ginesty, C. Perrault, C. Garcia-Echeverria, G. McCort, L. Schio, J. Med. Chem. 2020, 63, 512.
K. J. Skowron, K. Booker, C. Cheng, S. Creed, B. P. David, P. R. Lazzara, A. Lian, Z. Siddiqui, T. E. Speltz, T. W. Moore, Mol. Cell. Endocrinol. 2019, 493, 110471.
K. Merenbakh-Lamin, N. Ben-Baruch, A. Yeheskel, A. Dvir, L. Soussan-Gutman, R. Jeselsohn, R. Yelensky, M. Brown, V. A. Miller, D. Sarid, S. Rizel, B. Klein, T. Rubinek, I. Wolf, Cancer Res. 2013, 73, 6856.
P. G. Alluri, C. Speers, A. M. Chinnaiyan, Breast Cancer Res. 2014, 16, 494.
E. Belachew, T. Sewasew, Front. Endocrinol. 2021, 12, 1.
C. A. Walsh, L. Qin, J. C. Y. Tien, L. S. Young, J. Xu, Int. J. Biol. Sci. 2012, 8, 470.
X. Puyang, C. Furman, G. Z. Zheng, Z. J. Wu, D. Banka, K. Aithal, S. Agoulnik, D. M. Bolduc, S. Buonamici, B. Caleb, S. Das, S. Eckley, P. Fekkes, M. H. Hao, A. Hart, R. Houtman, S. Irwin, J. J. Joshi, C. Karr, A. Kim, N. Kumar, P. Kumar, G. Kuznetsov, W. G. Lai, N. Larsen, C. Mackenzie, L. A. Martin, D. Melchers, A. Moriarty, T. V. Nguyen, J. Norris, M. O'Shea, S. Pancholi, S. Prajapati, S. Rajagopalan, D. J. Reynolds, V. Rimkunas, N. Rioux, R. Ribas, A. Siu, S. Sivakumar, V. Subramanian, M. Thomas, F. H. Vaillancourt, J. Wang, S. Wardell, M. J. Wick, S. Yao, L. Yu, M. Warmuth, P. G. Smith, P. Zhu, M. Korpal, Cancer Discov. 2018, 8, 1176.
A. A. Parent, J. R. Gunther, J. A. Katzenellenbogen, J. Med. Chem. 2008, 51, 6512.
Y. Wang, N. Y. Chirgadze, S. L. Briggs, S. Khan, E. V. Jensen, T. P. Burris, Proc. Natl Acad. Sci. USA 2006, 103, 9908.
A. L. Rodriguez, A. Tamrazi, M. L. Collins, J. A. Katzenellenbogen, J. Med. Chem. 2004, 47, 600.
D. Shao, T. J. Berrodin, E. Manas, D. Hauze, R. Powers, A. Bapat, D. Gonder, R. C. Winneker, D. E. Frail, J. Steroid. Biochem. Mol. Biol. 2004, 88, 351.
K. Singh, R. S. N. Munuganti, N. Lallous, K. Dalal, J. S. Yoon, A. Sharma, T. Yamazaki, A. Cherkasov, P. S. Rennie, Int. J. Mol. Sci. 2018, 19, 1.
N. Gibitz Eisath, Diploma Thesis, University of Innsbruck, Innsbruck 2014.
K. Singh, Ph.D. Thesis, The University Of British Columbia, Vancouver 2007.
L. A. Haldosén, C. Zhao, K. Dahlman-Wright, Mol. Cell. Endocrinol. 2014, 382, 665.
A. K. Knox, C. Kalchschmid, D. Schuster, F. Gaggia, R. Gust, J. Med. Chem. 2021, 64, 5766.
A. Knox, Ph.D. Thesis, University of Innsbruck, Innsbruck 2018.
A. K. Shiau, D. Barstad, P. M. Loria, L. Cheng, P. J. Kushner, D. A. Agard, G. L. Greene, Cell 1998, 95, 927.
T. Saha, S. Makar, R. Swetha, G. Gutti, S. K. Singh, Eur. J. Med. Chem. 2019, 177, 116.
I. Paterni, C. Granchi, J. A. Katzenellenbogen, F. Minutolo, Steroids 2014, 90, 13.
C. De Savi, R. H. Bradbury, A. A. Rabow, R. A. Norman, C. de Almeida, D. M. Andrews, P. Ballard, D. Buttar, R. J. Callis, G. S. Currie, J. O. Curwen, C. D. Davies, C. S. Donald, L. J. L. Feron, H. Gingell, S. C. Glossop, B. R. Hayter, S. Hussain, G. Karoutchi, S. G. Lamont, P. MacFaul, T. A. Moss, S. E. Pearson, M. Tonge, G. E. Walker, H. M. Weir, Z. Wilson, J. Med. Chem. 2015, 58, 8128.
A. Knox, C. Kalchschmid, D. Schuster, F. Gaggia, C. Manzl, D. Baecker, R. Gust, Eur. J. Med. Chem. 2020, 192, 1.
V. Obermoser, D. Baecker, C. Schuster, V. Braun, B. Kircher, R. Gust, Dalton Trans. 2018, 47, 4341.
G. Jones, P. Willett, R. C. Glen, A. R. Leach, R. Taylor, J. Mol. Biol. 1997, 267, 727.
A. Volkamer, D. Kuhn, T. Grombacher, F. Rippmann, M. Rarey, J. Chem. Inf. Model. 2012, 52, 360.
A. Volkamer, D. Kuhn, F. Rippmann, M. Rarey, Bioinformatics 2012, 28, 2074.

Auteurs

Nikolas Hörmann (N)

Department of Pharmaceutical Chemistry, Institute of Pharmacy, Center for Molecular Bioscience Innsbruck, Innsbruck, Austria.

Christina Kalchschmid (C)

Department of Pharmaceutical Chemistry, Institute of Pharmacy, Center for Molecular Bioscience Innsbruck, Innsbruck, Austria.

Patricia Grabher (P)

Department of Pharmaceutical Chemistry, Institute of Pharmacy, Center for Molecular Bioscience Innsbruck, Innsbruck, Austria.

Isabella Grassmayr (I)

Department of Pharmaceutical Chemistry, Institute of Pharmacy, Center for Molecular Bioscience Innsbruck, Innsbruck, Austria.

Paul Kapitza (P)

Department of Pharmaceutical Chemistry, Institute of Pharmacy, Center for Molecular Bioscience Innsbruck, Innsbruck, Austria.

Teresa Kaserer (T)

Department of Pharmaceutical Chemistry, Institute of Pharmacy, Innsbruck, Austria.

Ronald Gust (R)

Department of Pharmaceutical Chemistry, Institute of Pharmacy, Center for Molecular Bioscience Innsbruck, Innsbruck, Austria.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH